STOCK TITAN

CMI (NYSE) brokered notice: 607 vested shares, $421K (Form 144)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CMI reports a proposed sale of $421,294.42 worth of Common stock comprising 607 shares, disclosed on 05/11/2026. The filing states the shares vested as restricted stock under a registered plan with a vesting/transfer date of 03/01/2026, and the broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies the market of an intended brokered sale of vested restricted shares.

The notice lists 607 shares vesting under a registered plan on 03/01/2026 and an aggregate amount of $421,294.42. The broker identified is Morgan Stanley Smith Barney LLC.

Cash‑flow treatment and whether proceeds go to the issuer or selling holder are not stated in the excerpt; timing is governed by broker procedures and Rule 144 resale mechanics.

Shares to be sold 607 shares restricted stock vesting on <date>03/01/2026</date>
Aggregate amount $421,294.42 amount shown adjacent to the security line in the filing
Filing date 05/11/2026 Form 144 disclosure date
Form 144 regulatory
"Filer Information | 144: Filer Information | 144: Issuer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
restricted stock vesting financial
"Restricted stock vesting under a registered plan | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
registered plan regulatory
"Restricted stock vesting under a registered plan"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CMI's Form 144 filing disclose?

The filing discloses a proposed sale of 607 shares of Common stock vesting under a registered plan on 03/01/2026, with an aggregate amount of $421,294.42, brokered by Morgan Stanley Smith Barney LLC.

Who is listed as the broker for the proposed sale in CMI's Form 144?

The broker is listed as Morgan Stanley Smith Barney LLC Executive Financial Services. The notice names the executing broker and indicates the transaction method but does not specify settlement timing or net proceeds recipients.

When did the restricted shares vest according to the filing?

The restricted shares vesting/transfer date is stated as 03/01/2026. The Form 144 shows the vesting date and the proposed sale disclosure dated 05/11/2026, consistent with resale notice timing.

How much value is associated with the shares in the Form 144?

The filing shows an aggregate amount of $421,294.42 associated with 607 shares. The document does not provide per‑share price or proceeds allocation beyond this aggregate figure.